医药企业社会责任研究——基于CiteSpace视角
Research on Social Responsibility of Pharmaceutical Companies—Based on the Perspective of CiteSpace

基于2002~2022年中国知网数据库中收录的有关医药企业社会责任的279篇学术期刊文献，利用“CiteSpace”软件针对医药企业社会责任研究进行系统性梳理，绘制了研究机构、关键词聚类、研究热点演替的可视化图谱。得出结论：针对医药企业社会责任的深入研究仍较为缺乏；不同研究机构间尚未形成紧密的合作网络；研究热点聚焦在“信息披露”、“药品”、“消费者”以及实证研究等方面；新的研究趋势与“信息披露”、“内部控制”、“因子分析”等词相关。并提出学者可在“新冠疫情”的背景下进一步研究等展望。
Based on 279 academic journal articles on pharmaceutical CSR included in CNKI’s database from 2002 to 2022, the “CiteSpace” software was used to systematically sort out the research on pharmaceutical corporate social responsibility, and a visual map of research institutions, keyword clustering, and research hotspot succession was drawn. The results show that: There is still a lack of in-depth research on pharmaceutical corporate social responsibility. A close network of cooperation has not yet been formed among different research institutions; Research hotspots still focus on “information disclosure”, “pharmaceuticals”, “consumers” and empirical research; New research trends are related to the terms “information disclosure”, “internal control”, “factor analysis”, etc. We also proposed prospects for scholars to conduct further research in the context of the “covid epidemic”.